New Clinical Trials for High Cholesterol

High cholesterol has dangerous affects on arteriesHigh cholesterol is an important condition to diagnose, manage and treat, both on its own and as an indicator of other problems. If you have high cholesterol and have tried to treat it unsuccessfully with diet and exercise, or even with medication, we would like to talk to you. There is much more to learn and ongoing high cholesterol clinical studies are needed.

(For more information, please see: High Cholesterol Symptoms, High Cholesterol Drugs & Medication, and High Cholesterol Causes)

There are ongoing high cholesterol clinical trials that you can participate in if you qualify. Please review the list and contact us if you are interested in participating. As always there is no cost to you to participate in clinical trials.

What is High Cholesterol?

High cholesterol, also known as hypercholesterolemia, is a condition where there are high levels of cholesterol in the blood. High cholesterol can have many causes, but the main one is heart disease. It is closely related to hyperlipidemia that occurs when there are a high number of lipids found in the blood. Diet, genetics, diabetes, and an under-active thyroid are other potential causes for high cholesterol. The U.S. Preventative Services Task Force recommends screening for high cholesterol as an early indicator of heart disease. Cholesterol is made up of different types of fat – LDL, HDL and VLDL. It is important to measure each when determining harmful levels of cholesterol.

High Cholesterol Treatments

High cholesterol treatments include lifestyle changes. In obese people with high cholesterol that has been caused by their diet, the condition can sometimes be improved when they improve their diet. Quitting smoking and reducing the intake of alcohol can also be helpful. If lifestyle changes don’t work, then drugs may be prescribed. The American College of Physicians has set some guidelines for the treatment of high cholesterol. Treating high cholesterol may involve the use of statins and lipid lowering therapies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
755 High Cholesterol
clinical trials

Cardiology / Vascular Diseases Clinical Trial
High Cholesterol Clinical Trial
Status: Upcoming
mi
from
DeLand, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Lipoproteins
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
Status: Enrolling
Updated: 3/15/2013
mi
from
Birmingham, AL
Click here to add this to my saved trials
Homozygous Familial Hypercholesterolemia Clinical Trial
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Reproductive Clinical Trial
Study of the Effects of Blackcurrant Extract and Omega-3 Fats on the Health of the Heart and Blood Vessels
Status: Enrolling
Updated: 4/20/2017
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling, Phase II
Updated: 8/21/2015
mi
from
Auburn, ME
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling, Phase II
Updated: 8/21/2015
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling, Phase II
Updated: 8/21/2015
mi
from
Richmond, VA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Chino, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Eugene, OR
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Ft Lauderdale, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Lyndhurst, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
mi
from
Stanford, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
mi
from
San Diego, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bronx, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Buckley, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Clearwater, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Covington, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Dunwoody, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Haverhill, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Hialeah, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Hollywood, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Kingsport, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Memphis, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Munster, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Omaha, NE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Plano, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Raleigh, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Schertz, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Shelby, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Valparaiso, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Victoria, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Other Clinical Trial
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Rochester, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
Cardiovascular Risk Screening and Risk Reduction in Women Vets
Status: Enrolling
Updated: 12/31/1969
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Pharmacology / Toxicology Clinical Trial
Habitual Diet and Avocado Trial
Status: Enrolling
Updated: 12/31/1969
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Dyslipidemia of Obesity Intervention in Teens
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Complete Health Improvement Program (CHIP) Risk Reduction/Claims Evaluation Project
Status: Enrolling
Updated: 12/31/1969
mi
from
Athens, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Pharmacology / Toxicology Clinical Trial
Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Patients With Hypertriglyceridemia and Established Cardiovascular Disease (CVD)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
RiSE to Prevent Cardiovascular Disease in African Americans
Status: Enrolling
Updated: 12/31/1969
mi
from
Maywood, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Status: Enrolling
Updated: 6/23/2005
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Causes and Natural History of Dyslipidemias
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Immunology / Infectious Diseases, Pharmacology / Toxicology Clinical Trial
Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Status: Enrolling
Updated: 4/6/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling, Phase II
Updated: 8/21/2015
mi
from
Tustin, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Jacksonvile, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Louisville, KY
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Marietta, GA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Norfolk, VA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Port Orange, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Biomarkers in Aortic Stenosis - B.A.S.S.
Status: Enrolling, Phase
Updated: 3/21/2018
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Homozygous Familial Hypercholesterolemia Clinical Trial
A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology Clinical Trial
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Miami, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Albany, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Anderson, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bradenton, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cary, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Collierville, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
1 2 3 4 5 6 7 8